Point-of-care Diagnostics Market Analysis by Product (Cardiac Markers, Coagulation, Fertility, Infectious Diseases, Primary Care Systems, Decentralized Clinical Chemistry), by End User (Hospitals, Assisted Living Healthcare Facilities, Clinics, Home), and by Region - Forecast to 2029

The global point-of-care diagnostics market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Introduction of improved technologically facilitated products is a key driver for the growth of the global point-of-care diagnostics market. Additionally, increase in occurrence of infectious diseases globally and growth in the cases of target diseases are some of the other drivers propelling the market growth. Nevertheless, high cost of point-of-care diagnostics devices in the emerging economies and incidence of unclear regulatory & repayment structure are expected to restrain the global market growth.

Global Point-of-care Diagnostics Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Product

Based on product, the market is segmented into glucose testing, lipid testing, Hb1Ac testing, cardiac markers, coagulation, fertility, infectious diseases, thyroid stimulating hormone, haematology, primary care systems, decentralized clinical chemistry, faeces, cancer marker, blood gas/electrolytes, ambulatory chemistry, drug abuse testing, and     urinalysis. In 2021, the infectious diseases segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to rise in cases of infectious and chronic diseases along with shift from centralized laboratories to decentralized point-of-care testing worldwide. Cardiac markers segment projected to grow at a profitable CAGR during the forecast period. This is attributed to increase in accurateness rates allied with these markers and the growing occurrence of target diseases.

By End User

Based on end user, the market is segmented into hospitals, assisted living healthcare facilities, clinics, home, and laboratory. In 2021, the clinics segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to growth in access for patients to new diagnostic technologies along with refining healthcare coverage worldwide. Home segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the application of point of care devices in the home healthcare sector that has permitted patients to address healthcare challenges at home and take judgements promptly.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the quickly increasing COVID-19 cases, presence of major players in the region, growth in initiatives from government, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the increasing cases of chronic and targeted diseases in various countries, growing government and corporate investment in healthcare sector, increase in the adoption of scale down models resulting in procedures adopted for the decrease in hospital stays are the major factors in this region.

Competitor Insights

Some of the key players in the point-of-care diagnostics market are F. Hoffmann-La Roche AG (Switzerland); QIAGEN (Germany); Danaher Corporation (U.S.); Becton, Dickinson and Company (U.S.); bioMérieux SA (France); Abbott Laboratories (U.S.); Siemens Healthineers AG (Germany); Zoetis, Inc. (U.S.); Home Diagnostics, Inc. (U.S.); Instrumentation Laboratory Company (U.S.); and Nova Biomedical Corporation (U.S.). The leading players operating in the point-of-care diagnostics industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2018 to 2026. The point-of-care diagnostics market report is categorized into the following segments and subsegments:

Point-of-care Diagnostics Market, By Product (Revenue, USD Billion, 2021 – 2029)

  • Glucose Testing
  • Lipid Testing
  • Hb1Ac Testing
  • Cardiac Markers
  • Coagulation
  • Fertility
  • Infectious Diseases
    • HIV POC
    • Clostridium Difficile POC
    • HBV POC
    • Pneumonia or Streptococcus Associated Infections
    • Respiratory Syncytial Virus (RSV) POC
    • HPV POC
    • Influenza/Flu POC
    • HCV POC
    • MRSA POC
    • TB and Drug-Resistant TB POC
    • HSV POC
    • COVID-19
    • Other Infectious Diseases
  • Thyroid Stimulating Hormone
  • Haematology
  • Primary Care Systems
  • Decentralized Clinical Chemistry
  • Faces
  • Cancer Marker
  • Blood Gas/Electrolytes
  • Ambulatory Chemistry
  • Drug Abuse Testing
  • Urinalysis

Point-of-care Diagnostics Market, By End User (Revenue, USD Billion, 2021 – 2029)

  • Hospitals
  • Assisted Living Healthcare Facilities
  • Clinics
    • Pharmacy & Retail Clinics
    • Physician Office
    • Urgent Care Clinic
    • Non-practice Clinics
  • Home
  • Laboratory

Point-of-care Diagnostics Market, By Region (Revenue, USD Billion, 2021 – 2029)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Global Point-of-care Diagnostics Market Size (USD Billion), 2021-2029

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Point-of-care Diagnostics Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Point-of-care Diagnostics
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Point-of-care Diagnostics Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Product
    1. Glucose Testing
      1. Glucose Testing Market Forecast, 2021-2029 (USD Million)
    2. Lipid Testing
      1. Lipid Testing Market Forecast, 2021-2029 (USD Million)
    3. Hb1Ac Testing
      1. Hb1Ac Testing Market Forecast, 2021-2029 (USD Million)
    4. Cardiac Markers
      1. Cardiac Markers Market Forecast, 2021-2029 (USD Million)
    5. Coagulation
      1. Coagulation Market Forecast, 2021-2029 (USD Million)
    6. Fertility
      1. Fertility Market Forecast, 2021-2029 (USD Million)
    7. Infectious Diseases
      1. Infectious Diseases Market Forecast, 2021-2029 (USD Million)
    8. Thyroid Stimulating Hormone
      1. Thyroid Stimulating Hormone Market Forecast, 2021-2029 (USD Million)
    9. Haematology
      1. Haematology Market Forecast, 2021-2029 (USD Million)
    10. Primary Care Systems
      1. Primary Care Systems Market Forecast, 2021-2029 (USD Million)
    11. Decentralized Clinical Chemistry
      1. Decentralized Clinical Chemistry Market Forecast, 2021-2029 (USD Million)
    12. Faces
      1. Faces Market Forecast, 2021-2029 (USD Million)
    13. Cancer Marker
      1. Cancer Marker Market Forecast, 2021-2029 (USD Million)
    14. Blood Gas/Electrolytes
      1. Blood Gas/Electrolytes Market Forecast, 2021-2029 (USD Million)
    15. Ambulatory Chemistry
      1. Ambulatory Chemistry Market Forecast, 2021-2029 (USD Million)
    16. Drug Abuse Testing
      1. Drug Abuse Testing Market Forecast, 2021-2029 (USD Million)
    17. Urinalysis
      1. Urinalysis Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by End User
    1. Hospitals
      1. Hospitals Market Forecast, 2021-2029 (USD Million)
    2. Assisted Living Healthcare Facilities
      1. Assisted Living Healthcare Facilities Market Forecast, 2021-2029 (USD Million)
    3. Clinics
      1. Clinics Market Forecast, 2021-2029 (USD Million)
    4. Home
      1. Home Market Forecast, 2021-2029 (USD Million)
    5. Laboratory
      1. Laboratory Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Point-of-care Diagnostics Market
    1. North America Point-of-care Diagnostics Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by End User, 2021-2029 (USD Million)
      2. S. Point-of-care Diagnostics Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by End User, 2021-2029 (USD Million)
        2. Canada Point-of-care Diagnostics Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by End User, 2021-2029 (USD Million)
  1. Europe Point-of-care Diagnostics Market
    1. Europe Point-of-care Diagnostics Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by End User, 2021-2029 (USD Million)
      2. Germany Point-of-care Diagnostics Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by End User, 2021-2029 (USD Million)
        2. UK Point-of-care Diagnostics Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by End User, 2021-2029 (USD Million)
          2. France Point-of-care Diagnostics Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by End User, 2021-2029 (USD Million)
            2. Spain Point-of-care Diagnostics Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by End User, 2021-2029 (USD Million)
              2. Italy Point-of-care Diagnostics Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  2. Market Size and Forecast by End User, 2021-2029 (USD Million)
                2. Rest of Europe Point-of-care Diagnostics Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    2. Market Size and Forecast by End User, 2021-2029 (USD Million)
  1. Asia Pacific Point-of-care Diagnostics Market
    1. Asia Pacific Point-of-care Diagnostics Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by End User, 2021-2029 (USD Million)
      2. Japan Point-of-care Diagnostics Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by End User, 2021-2029 (USD Million)
        2. China Point-of-care Diagnostics Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by End User, 2021-2029 (USD Million)
          2. India Point-of-care Diagnostics Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by End User, 2021-2029 (USD Million)
            2. South Korea Point-of-care Diagnostics Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by End User, 2021-2029 (USD Million)
                3. Market Size and Forecast by Device, 2021-2029 (USD Million)
              2. Australia Point-of-care Diagnostics Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                  2. Market Size and Forecast by End User, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Point-of-care Diagnostics Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                    2. Market Size and Forecast by End User, 2021-2029 (USD Million)
  1. Latin America Point-of-care Diagnostics Market
    1. Latin America Point-of-care Diagnostics Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by End User, 2021-2029 (USD Million)
      2. Brazil Point-of-care Diagnostics Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by End User, 2021-2029 (USD Million)
        2. Mexico Point-of-care Diagnostics Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by End User, 2021-2029 (USD Million)
          2. Argentina Point-of-care Diagnostics Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by End User, 2021-2029 (USD Million)
            2. Rest of Latin America Point-of-care Diagnostics Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Product, 2021-2029 (USD Million)
                2. Market Size and Forecast by End User, 2021-2029 (USD Million)
  1. MEA Point-of-care Diagnostics Market
    1. MEA Point-of-care Diagnostics Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Product, 2021-2029 (USD Million)
        2. Market Size and Forecast by End User, 2021-2029 (USD Million)
      2. GCC Point-of-care Diagnostics Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Product, 2021-2029 (USD Million)
          2. Market Size and Forecast by End User, 2021-2029 (USD Million)
        2. South Africa Point-of-care Diagnostics Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Product, 2021-2029 (USD Million)
            2. Market Size and Forecast by End User, 2021-2029 (USD Million)
          2. Rest of MEA Point-of-care Diagnostics Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Product, 2021-2029 (USD Million)
              2. Market Size and Forecast by End User, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Hoffmann-La Roche AG (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. QIAGEN (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Danaher Corporation (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. Becton, Dickinson and Company (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. bioMérieux SA (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Abbott Laboratories (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Siemens Healthineers AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Zoetis, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Home Diagnostics, Inc. (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. Instrumentation Laboratory Company (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Nova Biomedical Corporation (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports